- Drugs
- Tuesday, 05 May 2020
Verde Leaf™ Appoints Carl L. Powell as Chairman
Verde Leaf™ is pleased to announce the selection and appointment of Mr. Carl L Powell as Chairman. Verde Leaf™ will draw on Mr. Powell's decades of experience in building successful businesses to help evaluate the numerous opportunities that Verde Leaf™ is considering and assist with the execution strategies for existing divisions. Additionally, Powell will also assist the company with developing the proper capital markets strategies and the evaluation of strategic partners.
Mr. Powell has extensive experience operating in global public markets, having served in senior executive capacities for several companies and on a diverse board of directors across many industries. He is currently President of Integral Emerging Markets and Investment divisions, affiliates of the Integral Group which provides advisory, infrastructure and real estate and private equity to emerging sectors in Africa and Caribbean, and certain targeted sectors in the United States. He also manages the firms Equity and Debt Funds.
Mr. Powell holds a Master of Business Administration from Harvard University and is a Hall of Fame Graduate from the University of Mississippi. Mr. Powell serves on several boards including the Atlanta Downtown Improvement District, Micro Dynamics LLC, Precision Jet LLC, Turfbond LLC, Diversified BioImaging, Integral-SICAP Developments (Dakar Senegal), H2ForLife Waters, and the VII Group.
"Carl's successful track record in capital markets and his extensive experience in private equity and strategy development will be a great addition to the Verde Leaf™ team as we continue to grow operations and seek new opportunities," said Dr. Jackson Garth, President, and CEO of Verde Leaf™.
"I've always had a very strong interest in companies focused on providing natural products for the health and heeling of body, as well as maximizing synergies across a value system. Jackson and his team has done excellent job of creating a vertically integrated portfolio of companies that allow the tracing and extraction of hemp products from genetics all the way to end use pharmaceutical and retail products. That's very appealing to me and I look forward to working with the team," said Carl Powell, Chairman of Verde Leaf™.
Related Industry Updates
MigVax appoints Eyal Desheh, former Teva, Check Point executive, as chairman
Jun 09, 2020
TOWA PHARMACEUTICAL CO., LTD. reaches an agreement with ESTEVE to acquire ESTEVE's generic division, Pensa Investments
Dec 24, 2019
Oral Anti-Diabetes Drugs Market Size (Value & Volume), Future Trends, Opportunities and Sales Channels, Forecast 2027
Apr 06, 2021
Esteve acquires German proprietary, specialty, hospital-focused company Riemser and expands its presence in Europe
Jan 08, 2020
Acute Pancreatitis Market is expected to reach US$ 8,827.37 million by 2030
Sep 08, 2023
Ionis Pharmaceuticals to present at upcoming virtual investor conferences
Jun 05, 2020
Sea Water Nasal Spray Market is expected to reach US$ 3,812.22 million by 2030
Jan 16, 2024